R. Gorodetsky et al., SUB-ADDITIVE EFFECT OF THE COMBINATION OF RADIATION AND CISPLATIN IN CULTURED MURINE AND HUMAN CELL-LINES, Israel journal of medical sciences, 31(2-3), 1995, pp. 95-100
The use of cisplatin (CDDP) as a potential radiosensitizer in tumors i
s controversial. Reports about CDDP interaction with radiation range f
rom high radiosensitization to a dear sub-additive effect. We examined
the effect of the combination of different concentrations of CDDP wit
h radiation in murine mammary adenocarcinoma (EMT-6) and human ovarian
carcinoma (OV-1063) cell lines. CDDP was given in the dose range of 0
.01-3.0 mu g/ml and radiation in the dose range of 1-6 Gy. A methylene
blue assay of cell density was used for the evaluation of cell surviv
al and rate of proliferation in 96-microwell plates. The validity of t
his assay for evaluation of cell survival was verified by colony-formi
ng assay and radiolabeled thymidine uptake. The dose response to CDDP
for both OV-1063 and EMT-6 cells lines was examined; the ID50 was 0.06
and 0.9 mu g/ml respectively. A sub-additive effect of the combinatio
n of radiation with CDDP was clearly observed in the two cell lines te
sted; the increase in dose of each modality resulted in a decrease of
the relative contribution on the effect of the other. These findings q
uestion the rationale of combining CDDP with radiation for the enhance
ment of tumor response, since with the increase in the dose of either
modality the additional effect of the other decreases.